Liu W, Linn S
Division of Biochemistry and Molecular Biology, 229 Stanley Hall, University of California, Berkeley, CA 94720-3206, USA.
Nucleic Acids Res. 2000 Nov 1;28(21):4180-8. doi: 10.1093/nar/28.21.4180.
Human DNA polymerase epsilon (pol epsilon) normally contains a 261-kDa catalytic subunit (p261), but from some sources it is isolated as a 140-kDa catalytic core of p261. This shortened form possesses normal or somewhat enhanced polymerase activity and its significance is unknown. We report here that caspase-3 and calpain can form p140 from p261 in vitro and in vivo and that during early stages of apoptosis induced in Jurkat cells by staurosporine or anti-Fas-activating antibody, p261 is cleaved into p140 by caspase-3. At later stages, activated calpain might also contribute to this conversion. The sites of cleavage by caspase-3 have been identified, and mutations at these 'DEAD boxes' resulted in cleavage-resistant enzyme. Cleavage at these sites separates the 'N-terminal catalytic core' from the 'C-terminal' regions described for p261. Cleavage does not occur during necrosis or following exposure to H(2)O(2) or methanesulfonic acid methyl ester. p140 is unlikely to be able to functionally replace p261 in vivo, since it does not bind to PCNA or the other pol epsilon subunits.
人类DNA聚合酶ε(pol ε)通常含有一个261 kDa的催化亚基(p261),但从某些来源分离得到的却是p261的140 kDa催化核心。这种缩短形式具有正常或略有增强的聚合酶活性,其意义尚不清楚。我们在此报告,半胱天冬酶-3(caspase-3)和钙蛋白酶在体外和体内均可将p261切割形成p140,并且在星形孢菌素或抗Fas激活抗体诱导Jurkat细胞凋亡的早期阶段,p261被caspase-3切割成p140。在后期阶段,活化的钙蛋白酶可能也参与了这种转化。已确定了caspase-3的切割位点,这些“DEAD框”处的突变导致酶对切割具有抗性。这些位点的切割将“N端催化核心”与p261的“C端”区域分开。在坏死过程中或暴露于过氧化氢或甲磺酸甲酯后不会发生切割。p140在体内不太可能在功能上替代p261,因为它不与增殖细胞核抗原(PCNA)或其他pol ε亚基结合。